Ortivus (ORTI) Q2 2024 earnings summary

Executive summary

• Extensive transformation efforts included a 20% workforce reduction, management consolidation, and ERP implementation to drive efficiency and profitability.

• Focus shifted toward a license-based software model for improved scalability, gross margins, and recurring revenues.

• Major customer deliveries in Estonia and Jönköping for MobiMed ePR are on track for completion by year-end.

• The period was impacted by costs related to a prior cyberattack, management transition, and restructuring.

• Two new contracts were secured with existing customers in Norrbotten and Örebro, signaling strong market position.

Financial highlights

• Net sales for Q2 2024 were 17.7 MSEK, down from 20.7 MSEK year-over-year; H1 2024 net sales were 39.7 MSEK, down from 48.7 MSEK.

• Gross margin for Q2 was 30% (vs. 37% prior year); H1 gross margin was 36% (vs. 43%).

• Net income after tax for Q2 was -8.3 MSEK (vs. -4.8 MSEK); H1 net income was -10.5 MSEK (vs. -4.6 MSEK).

• Operating profit for Q2 was -7.8 MSEK (vs. -4.7 MSEK); H1 operating profit was -9.9 MSEK (vs. -4.2 MSEK).

• Earnings per share for Q2 were -0.19 SEK (vs. -0.11 SEK); H1 EPS was -0.24 SEK (vs. -0.10 SEK).

Outlook and guidance

• Transformation costs are expected to yield a lower cost base in H2 2024, with improved profitability anticipated.

• Customer deliveries in Estonia and Jönköping are expected to be completed before year-end.

• Ongoing compensation processes related to the cyberattack are targeted for resolution by year-end.